A simple treatment algorithm to aid in the selection of appropriate DMTs reduces racial disparities in patients with ...

Survey results show that clinicians largely disagree about choices for severe asthma treatment, due primarily to a lack of ...

Treatment with donanemab (Kisunla) raised the risk of amyloid-related imaging abnormalities (ARIA) in people with early ...

Biopharma companies require optimal clone yields to ensure maximum concentration and effectiveness of these therapeutic ...

Notably, and consistent with all dominant variants for the past three years, LP.8.1 did not generate any meaningful change to the neutralization activity of pemivibart or VYD2311, the company’s next ...

Introduction: the need for advanced monitoring in shake flasks. Shake flasks have been a cornerstone of biotechnological ...

Sleep is essential for overall health and well-being, yet it remains one of the most overlooked aspects of healthcare. This World Sleep Day, under the theme "Make Sleep Health a Priority," BMC Medical ...

Monoclonal antibodies dupilumab (Dupixent ... Given a number of choices in the field, selection of one biologic over another would likely follow patient preferences, prioritizing oral medications ...

Detailed price information for Fate Therapeutics (FATE-Q) from The Globe and Mail including charting and trades.